MarketInOut Stock Screener Log In | Sign Up

Certara Inc

NASDAQ • Healthcare • Health Information Services • Quote as of 11/06/2026 16:00
Certara Inc stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,852.58 mln
Float97.12 mln
Earnings Date03/04/2027

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.76
Likely reliable

1-Year Forecast

9.17
Downside risk

Relative Strength

95 / 100
Top performer

Debt / Equity

0.31
Low leverage

Pre-Tax Margin

-4%
Marginally loss-making

Business Description

Certara helps pharmaceutical companies develop safer and more effective drugs by using advanced computer modeling to predict how medicines will behave in the human body. Founded in 2008 and based in Radnor, Pennsylvania, the company offers a broad range of software tools and expert services that support every stage of drug development, from early research through to regulatory approval and market entry. Its solutions are used by clients across North and South America, Europe, the Middle East, Africa, and the Asia Pacific region.

Key Fundamentals

EPS-0.18
ROE-0.28
RPS2.64
ROIC1.41
ROA-0.19
Interest Cover0.94
EBITDA, mln75.70
EV / EBITDA26.10
EV / EBIT775
Revenue, mln408
EV / Revenue4.84

Quote Details

Last 12.05
Change -0.13 (-1.07%)
Open 12.03
Volume 4,871,017
Turnover 58,695,756
Average Volume 2,465,647

Financial Ratios

Pre-Tax Profit Margin-4
Leverage Ratio1.45
Current Ratio2.55
Price / Book1.91
Price / Cash Flow22.82
Price / Free Cash Flow23.91
Debt / Equity0.31
Price / Sales4.69
PEG Ratio7.11

Financial Strength

Altman Z-Score2.84
Piotroski F-Score 6 / 9
Beneish M-Score-2.76
Price to Intrinsic Value1.25
Price to Lynch Fair Value6.95
1-Year Target Price9.17
Short Ratio8.41
Short % of Float26.37

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 9.35% 93 / 100   
1 Month 39.47% 98 / 100   
2 Months 47.31% 98 / 100   
6 Months 90.97% 98 / 100   
1 Year 4.15% 58 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog